DATA AVAILABILITY STATEMENT
The data that support the findings of this study are not publicly available due to intellectual property restrictions and informed consent not including provisions for dissemination of the data; however, the data are available from the corresponding author upon reasonable request. Furthermore, our study design had three parts: Part A was conducted as a randomized, double‐blind, placebo‐controlled study in Japanese healthy adults, White healthy adults, and Japanese elderly; Part B was conducted as a randomized, open‐label, 2‐way crossover study in Japanese healthy adults; Part C was conducted as a randomized, double‐blind, 3‐way crossover study in Japanese healthy adults. The number of patients in each treatment group is less than 10. Wherever possible data has been presented as mean (SD) or 95% CI. Also, there was no data imputation. Therefore, we do not believe that the outlier data points are of significance requiring the presentation of raw data.